Comparison of the effects of vasoactive agents on adenylate cyclase activity in endothelial and smooth muscle cells from the same specimen of fetal bovine aorta

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 1, 1996, Pages 36-42

  Ashikaga, Takashi ^a   Kishi, Yukio ^a   Numano, Fujio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Adenylate cyclase; Endothelial cells; Smooth muscle cells

Indexed keywords

ADENINE; ADENYLATE CYCLASE; CATECHOLAMINE; FORSKOLIN; NORADRENALIN; PROSTAGLANDIN E1;

ANIMAL; AORTA; ARTICLE; CATTLE; DOSE RESPONSE; DRUG EFFECT; METABOLISM; VASCULAR SMOOTH MUSCLE;

ADENINE; ADENYLATE CYCLASE; ALPROSTADIL; ANIMALS; AORTA; CATECHOLAMINES; CATTLE; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE;

EID: 0029689585     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb03059.x     Document Type: Review

References (41)

1. Furchgott RF. Role of endothelium in responses of vascular smooth muscle. Circ. Res. 1983; 53: 557-73.
2. Simionescu M, Simionescu N. Functions of endothelial cell surface. Annu. Rev. Phys. Chem. 1986; 48: 279-93.
3. Sutherland EW. Cyclic AMP and hormone action. In: Robinson GA, Butcher RW, Sutherland EW (eds) Cyclic AMP. Academic Press, New York. 1971; pp. 17-47.
4. Numano F. Cyclic nucleotides and atherosclerosis. In: Cehovic G, Robinson G (eds). Cyclic Nucleotides and Therapeutic Perspectives. Pergamon Press, Oxford. 1979; pp. 137-46.
5. Furchgott RF, Zawadzki JV. The obligatory role of the endothelial cells in the relaxation of arterial vascular smooth muscle by acetylcholine. Nature 1980; 263: 663-5.
6. Moncada S, Vane JR. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N. Engl. J. Med. 1986; 300: 1142-7.
7. Yanagisawa M, Kurihara H, Kimura S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-15.
8. 2 on transport of fluorescein dextran through an arterial endothelial monolayer. Biochem. Pharmacol. 1987; 36: 3809-13.
9. Minnear FL, DeMichele MAA, Moon DG, Rieder CL, Fenton JW. II Isoproterenol reduces thrombin-induced pulmonary endothelial permeability in vitro. Am. J. Physiol. 1987; 257: H1613-23.
10. 2+ and cyclic AMP in the regulation of production of prostacyclin by the vascular endothelium. Proc. Natl Acad. Sci. USA 1982; 79: 495-9.
11. Stout RW. Cyclic AMP: A potent inhibitor of DNA synthesis in cultured arterial endothelial and smooth muscle cells. Diabetologia 1982; 22: 51-5.
12. Blaes N, Boissel JP. Growth stimulating effect of cathecholamines on rat aortic smooth muscle cells in culture. J. Cell Physiol. 1983; 116: 167-72.
13. Jones AW, Bylund DB, Forte LR. cAMP-dependent reduction in membrane fluxes during relaxation of arterial smooth muscle. Am. J. Physiol. 1984; 246: H306-11.
14. Schwarz SM. Selection and characterization of bovine aortic endothelial cells. In Vitro 1978; 14: 966-80.
15. Ross R. The smooth muscle cell. II. Growth of smooth muscle cell in culture and formation of elastic fibers. J. Cell Biol. 1971; 50: 172-86.
16. Kishi Y, Numano F. In vitro study of vascular endothelial injury by activated platelets and its prevention. Atherosclerosis 1989; 76: 95-101.
17. Tsukada T, Tippens D, Gordon D, Ross R, Gown AM. HHF35, a muscle-actin-specific monoclonal antibody. Immunocytochemical and biochemical characterization. Am. J. Pathol. 1987; 126: 51-60.
18. Koh E, Morimoto S, Takamoto S et al. Effects of valinomycin on calcium mobilization in vascular smooth muscle cells induced by angiotensin II. Biochem. Biophys. Res. Commun. 1989; 162: 491-7.
19. Neer EJ, Cock JM, Wolf LG. Purification and properties of the inhibitory guanine nucleotide regulatory unit of brain adenylate cyclase. J. Biol. Chem. 1984; 259: 14 222-9.
20. Kishi Y, Ashikaga T, Numano F. Inhibition of platelet aggregation by prostacyclin is attenuated after exercise in patients with angina pectoris. Am. Heart J. 1992; 123: 291-7.
21. Salomon Y. Adenylate cyclase assay. Adv. Cyclic Nucl. Res. 1979; 10: 35-55.
22. Lowry OH, Rosebrough NJ, Fall AL, Randall RA. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951; 193: 265-75.
23. Shimizu H, Daly JW, Creveling CR. A radioisotopic method for measuring the formation of cyclic AMP in incubated slices of brain. J. Neurochem. 1969; 16: 1609-19.
24. Kishi Y, Nishiyama K, Numano F. Cyclic AMP accumulation in rabbit aorta smooth muscle cells altered in the presence of hyperlipidemic serum. Atherosclerosis 1985; 56: 213-22.
25. Kishi Y, Ashikaga T, Watanabe R, Numano F. Atrial natriuretic peptide reduces cyclic AMP by activating cyclic GMP-stimulated phosphodiesterase in vascular endothelial cells. J. Cardiovasc. Pharmacol. 1994; 24: 351-7.
26. Betz E. Cell culture systems to study progression and intimal proliferation. Basic Res. Cardiol. 1991; 86: 79-86.
27. Buonassisi V, Venter JG. Hormone and neurotransmitter receptors in an established vascular endothelial cell line. Proc. Natl Acad. Sci. USA 1981; 73: 1612-16.
28. Makarski JS. Stimulation of cyclic AMP production by vasoactive agents in cultured bovine aortic and pulmonary artery endothelial cells. In Vitro 1981; 17: 450-8.
29. Ager A, Gordon JL. Effect of vasoactive and inflammatory agents on cyclic AMP levels in W138 fibroblasts, endothelial and vascular smooth muscle cells in culture. Agents Actions 1980; 10: 569-72.
30. 2. Biochem. Biophys. Res. Commun. 1980; 96: 1640-7.
31. Schafer AI, Gimbrone MA Jr, Handin RI. Regulation of endothelial cell function by cyclic nucleotides. In: Jaffe EA (ed). Biology of Endothelial Cells. Martinus Nijhoff, Boston. 1984; pp. 248-58.
32. Steinberg SF, Jaffe EA, Bilezikian JP. Endothelial cells contain beta adrenoceptors. Naunyn Schmiedebergs Arch. Pharmacol. 1984; 325: 310-13.
33. Maruyama I, Soejima Y. Up-regulation of thrombomodulin on cultured endothelial cells by cyclic AMP. Ann. N. Y. Acad. Sci. 1990; 598: 538-9.
34. Leitman DC, Siscus RP, Murad F. Forskolin, phosphodiesterase inhibitors and cyclic AMP anlogues inhibit proliferation of cultured bovine aortic endothelial cells. J. Cell Physiol 1989; 127: 237-43.
35. Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I. Calcitonin gene related peptide is a potent vasodilator. Nature 1985; 313: 54-6.
36. Crossman D, McEwan J, MacDermot J, MacIntyre I, Dollery CT. Human calcitonin gene-related peptide activates adenylate cyclase and releases prostacyclin from human umbilical vein endothelial cells. Br. J. Pharmacol. 1987; 92: 695-701.
37. Rücker W, Schrör K. Evidence for high affinity prostacyclin binding sites in vascular tissue: Radioligand studies with a chemically stable analogue. Biochem. Pharmacol. 1983; 32: 2405-10.
38. Dixon BS, Breckon R, Fortune J et al. Effects of kinins on cultured arterial smooth muscle. Am. J. Physiol. 1990; 258: C299-308.
39. Kahn CR, Schecter Y. Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In: Gilman AG, Rau TW, Nies AS, Taylor P (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th edn. Pergamon Press, New York. 1990; p. 1463.
40. Seamon KB, Daly JW. Forskolin: A unique diterpene activator of cyclic AMP-generating systems. J. Cyclic Nucl. Res. 1981; 7: 201-24.
41. Hepler JR, Gilman AG. G proteins. Trends Biochem. Sci. 1992; 17: 383-7.